DNMT3B and Hirschsprung disease: Specifically, a lower expression level of DNMT3b was detected in EPCs from HSCR patients, which led to a decrease of the global DNA methylation and the overexpression of DNMT3b target genes in these cells, as previously was described by our group [14, 15].